trending Market Intelligence /marketintelligence/en/news-insights/trending/E60DIzxm8fYeAMNcRDtlLQ2 content esgSubNav
In This List

McKesson's CFO to step down; replacement named

Video

S&P Capital IQ Pro | Unrivaled Sector Coverage

Video

S&P Capital IQ Pro | Powering Your Edge

Blog

Enterprises are missing out on 24B by not optimizing cloud spending not going multicloud

Blog

Investment Research Analysts Providing Greater Coverage on Inflation


McKesson's CFO to step down; replacement named

McKesson Corp. said Britt Vitalone will be appointed as CFO and executive vice president, effective Jan. 1, 2018.

Vitalone has been with McKesson since 2006 and currently serves as CFO and senior vice president of McKesson's U.S. pharmaceutical and specialty health segments.

James Beer, current CFO and executive vice president, will assist in a transition period into early 2018. He will join Atlassian, an enterprise collaboration company, as CFO, effective February 2018.

In addition, McKesson reaffirmed its outlook for fiscal 2018 adjusted EPS of $11.80 to $12.50.